Project Grant HT9425261E475
Award Date 9/1/26
Completion Date 8/31/29
Dollars Obligated $657K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98108, USA
Similar Awards
- The Defense Health Agency awarded Fred Hutchinson Cancer Center $1,092,877 on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to investigate air pollution exposure during military deployment and liver cancer risk among United States veterans. The three-year project runs through August 31, 2029, with performance based in Seattle, Washington. The award supports basic and applied biomedical research intended to transform health care for Service Members...
- The Defense Health Agency awarded the Seattle Institute for Biomedical and Clinical Research $1.1 million on June 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to investigate associations between military deployment and early-onset colorectal cancer mortality in veterans. The award, which represents a modification (P00001) transferring the grant from VA Connecticut Research and Education Foundation Inc., funds research activity through July 31, 2030, and is...
- The Defense Health Agency awarded a $1,412,826 Project Grant on September 1, 2023 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to conduct research through the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Identification of Risk and Early Detection Biomarkers for Liver Cancer," will support a 3-year study led by Dr. Towia Libermann at Bidmc, with a sub-award to Vanderbilt University Medical Center (VUMC) to assist with case...
- The Defense Health Agency (DHA) awarded the University of Washington a $543,285 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, with a completion date of July 31, 2028. This award supports research focused on transforming rhabdomyosarcoma treatment through the development and evaluation of new FDA-approved combination therapies. The project will be conducted at the University of Washington's Seattle, Washington location under the...
- The Defense Health Agency awarded the University of Washington $1,999,957 on September 30, 2026, as a project grant under the Military Medical Research and Development program (CFDA 12.420) to establish and operate a clinical research site for the 2026 Prostate Cancer Clinical Consortium. The University of Washington Office of Sponsored Programs, the entity receiving the award, will deliver clinical research site services from Seattle, Washington through September 29, 2030. The assistance type...
- The Defense Health Agency awarded a $598,130 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development program (CFDA 12.420). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. Specifically, the project will investigate the "Determinants of Lung Cancer-Associated Cachexia" over the period from February 15, 2025 to February 14, 2027. As a leading research...
- The Defense Health Agency awarded Vanderbilt University Medical Center $1.166 million on July 31, 2026, under the Military Medical Research and Development program (CFDA 12.420) to optimize lung cancer screening guidelines for all Americans. The project runs through July 30, 2029, with performance in Nashville, Tennessee. The assistance type is a Project Grant. The program supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American...
- The U.S. Defense Health Agency awarded a $5,149,107 Project Grant to the Fred Hutchinson Cancer Center in Seattle, WA, under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at "Defining Human Correlates of Super-Evasive Disseminated Tumor Cells, Their Pathological Relevance and How to Eradicate Them" over the period of July 1, 2025 to June 30, 2029. The research will be conducted by the prominent non-profit medical research...
- The Defense Health Agency awarded the University of Washington $1,397,452 on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support research on the dynamics of eccDNA chromatin topology and molecular structures shaping glioma treatment response. Work is performed in Seattle, Washington, and runs through August 31, 2029. The University of Washington's Office of Sponsored Programs administers the award as the recipient. The Military Medical Research...
- The Defense Health Agency awarded the University of Virginia $583,333 in Project Grant funding on July 31, 2026, under the Military Medical Research and Development program (CFDA 12.420) to optimize lung cancer screening guidelines for all Americans. The award carries a period of performance through July 30, 2029, with work performed in Charlottesville, Virginia. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health...